Polycythemia vera is a chronic myeloproliferative disorder characterized by a somatic mutation affecting JAK2 cytokine receptors that leads to the abnormal proliferation of myeloid hematopoietic cells. Here, JAK2 is linked to acquired polycythemia vera.